The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells

E. Agea, A. M. Russano, O. Bistoni, F. Spinozzi, F. M. deBenedictis (Ancona, Italy)

Source: Annual Congress 2003 - Non-steroidal drugs in the treatment of respiratory diseases
Session: Non-steroidal drugs in the treatment of respiratory diseases
Session type: Thematic Poster Session
Number: 705
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Agea, A. M. Russano, O. Bistoni, F. Spinozzi, F. M. deBenedictis (Ancona, Italy). The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells. Eur Respir J 2003; 22: Suppl. 45, 705

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The up-regulation of cysteinyl-leukotriene receptors on T cells
Source: Eur Respir J 2003; 22: Suppl. 45, 395s
Year: 2003

The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016


Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004

The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 132s
Year: 2004

Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells
Source: Eur Respir J 2005; 26: Suppl. 49, 346s
Year: 2005

Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018


Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes
Source: Eur Respir J 2004; 24: Suppl. 48, 129s
Year: 2004

Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019


Effects of a newly developed dual CysLT1 and CysLT2 receptor antagonist, ONO-RS-531, on antigen- and leukotriene D4-induced contractions of isolated human bronchi
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005

Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing VEGF expression
Source: Eur Respir J 2004; 24: Suppl. 48, 129s
Year: 2004

Upregulation of cysteinyl leukotriene receptors CysLT1 and CysLT2 by TGF-β1 and LTE4 on human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


The muscarinic receptors promote IL-8 release in airway epithelial cells via the pERK42/44 and NF-kB pathways
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006

Liver-X-receptor agonists, but not dexamethasone, inhibit leukotriene production from human white blood cells pretreated with GM-CSF and activated with fMLP
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


The perxisome proliferator-activated receptor gamma agonist, rosiglitazone, inhibits IL-8 synthesis by airway epithelial cells stimulated with monocyte-derived microparticles
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor
Source: Eur Respir J 2004; 24: Suppl. 48, 345s
Year: 2004

Inhibition of LPS-induced neutrophil recruitment in the lungs correlates with modulation of neutrophil CD11b expression using the selective CXCR2 receptor antagonist SB-656933
Source: Eur Respir J 2004; 24: Suppl. 48, 218s
Year: 2004

Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001